Source/Disclosures
Source: Healio Coverage
September 20, 2020
1 min read
Save

September’s top five retina articles

Source/Disclosures
Source: Healio Coverage
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Recent retina/vitreous articles discuss study results and new trials. Here are five popular items from the first half of September on Healio/OSN:

Alimera enrolls first patient in Iluvien trial

Alimera Sciences has initiated enrollment for its prospective Iluvien study New Day. Read more.

LumiThera receives NEI grant in support of clinical trial

LumiThera Inc. is the recipient of a $1.5 million grant from the National Eye Institute in support of a clinical trial investigating a new treatment for diabetes-related ocular pathology. Read more.

Lineage Cell Therapeutics receives grant to fund novel bio-retinal patch

Lineage Cell Therapeutics was awarded a grant worth more than $500,000 for the development of a bio-retinal patch for the treatment of retinal diseases. Read more.

Enspryng reduces risk, severity of relapse in neuromyelitis optica spectrum disorder

Enspryng lowered relapse severity in patients with neuromyelitis optica spectrum disorder, according to data from the double-masked periods of the SAkura phase 3 studies presented at the MSVirtual2020 meeting. Read more.

Lapse in care may yield lost visual acuity in AMD

Patients with neovascular age-related macular degeneration who have a 3 month or longer lapse of anti-VEGF treatment may experience unrecoverable loss of vision. Read more.